Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe additions include an automated PubMed publications note and a revision tag (Revision: v3.3.2). The deletions remove the older PubMed note and the previous revision tag (Revision: v3.2.0).SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the funding-status notice that warned about potential delays in updating information due to government funding. This does not modify the study details, eligibility criteria, or outcomes listed on the page.SummaryDifference0.3%

- Check35 days agoChange DetectedThe new screenshot shows minor layout and styling tweaks that do not modify study content, eligibility criteria, locations, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedMajor change: new version v3.2.0 plus a government operating status notice; removal of v3.1.0 indicates the update to the latest release.SummaryDifference2%

- Check70 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.SummaryDifference0.1%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.